Haleon earns distinction in the Family of Brands category for building enduring trust and consumer connection Award highlights Haleon’s leadership in purposeful innovation and consumer impact WARREN, N.J.–(BUSINESS WIRE)–Haleon, a global leader in consumer health, today announced it has been honored in Fast Company’s 2025 Brands That Matter list in the Family of Brands category, … [Read more…]
ANKTIVA plus BCG is the first immunotherapy for non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors, to receive a positive recommendation for marketing authorization in Europe. For patients whose disease does not respond to BCG, there are currently no authorized treatment options; the primary option is surgical removal … [Read more…]
Company Announcement Transaction adds petosemtamab, a late-stage asset with two Breakthrough Therapy Designations, to Genmab’s portfolio Transaction anticipated to be accretive to Genmab’s EBITDA by end of 2029 COPENHAGEN, Denmark–(BUSINESS WIRE)–Genmab A/S (Nasdaq: GMAB) (“Genmab”) announced today that the conditions, including the minimum tender condition, to the previously announced tender offer (the “Offer”) by … [Read more…]
Phase 3 findings show oral zoliflodacin to be non-inferior to the combination of ceftriaxone and azithromycin for the treatment of uncomplicated urogenital gonorrhea. Positive study results are a significant milestone in the development of a first-in-class single-dose, oral antibiotic against gonorrhea, including infections caused by drug-resistant Neisseria gonorrhoeae, an urgent public health threat and high-priority … [Read more…]
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Enveric Biosciences, Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a biotechnology company advancing next-generation neuroplastogenic small molecules to address psychiatric and neurological disorders, today announced the entry into definitive agreements for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 426,390 shares originally issued in February 2025 and … [Read more…]
A new Wolters Kluwer survey highlights AI adoption, key challenges in practice, and educational gaps for the fast-growing PA profession WALTHAM, Mass.–(BUSINESS WIRE)–According to new survey findings from Wolters Kluwer Health, AI is a fixture in clinical practice for physician assistants (PAs) – also referred to as physician associates – with 56% reporting daily use … [Read more…]
MERGE identifies key opportunities for health insurers to transform member portals and close experience gap CHICAGO–(BUSINESS WIRE)–MERGE, a leading marketing and technology agency, released new research today that found most health insurance portals are falling short of member expectations, creating frustration, inefficiency, and financial strain. The white paper, “The Portal Payoff: A Study of 13 … [Read more…]
Encouraged that at Least One Member of STAAR’s Board Recognizes the Flaws of the Sale Process and that the Go-Shop Process was Performative Questions Completeness of Disclosures Given Critical Omission of Inbound Interest from Respected Private Equity Firm that Indicated It Would Pay More than Alcon Notes That STAAR’s Board Did Not Obtain an Updated … [Read more…]
Leadership Changes to Take Effect Following Conclusion of Ordinary General Meeting of Shareholders in March 2026 Announcement Follows Year of Dual CEO / COO Model and Returns Company to Single Leader Structure TOKYO–(BUSINESS WIRE)–Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, today announced the Board of Directors’ decision to appoint … [Read more…]
MARSEILLE, France–(BUSINESS WIRE)–#immunotherapy–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today released its 2026 financial calendar: March 26, 2026: Publication of 2025 financial statements May 13, 2026: Publication of revenue and cash position for 1Q2026 May 21, 2026: Annual General Shareholders Meeting September 17, 2026: Publication of half year … [Read more…]
